Authors:
LE Q
DANIEL R
CHUNG SW
KANG AD
EISENSTEIN TK
SULTZER BM
SIMPKINS H
WONG PMC
Citation: Q. Le et al., INVOLVEMENT OF C-ABL TYROSINE KINASE IN LIPOPOLYSACCHARIDE-INDUCED MACROPHAGE ACTIVATION, The Journal of immunology, 160(7), 1998, pp. 3330-3336
Authors:
PAREKH H
PILLARISETTI K
KUNAPULI S
SIMPKINS H
Citation: H. Parekh et al., ISOLATION OF A HAMSTER CDNA HOMOLOGOUS TO THE MOUSE AND HUMAN CYCLIN KINASE INHIBITORY PROTEIN P27(KIP1), Somatic cell and molecular genetics, 23(2), 1997, pp. 147-151
Citation: H. Parekh et al., ACQUISITION OF TAXOL RESISTANCE VIA P-GLYCOPROTEIN-MEDIATED AND NON-P-GLYCOPROTEIN-MEDIATED MECHANISMS IN HUMAN OVARIAN-CARCINOMA CELLS, Biochemical pharmacology, 53(4), 1997, pp. 461-470
Citation: H. Parekh et H. Simpkins, CROSS-RESISTANCE AND COLLATERAL SENSITIVITY TO NATURAL PRODUCT DRUGS IN CISPLATIN-SENSITIVE AND RESISTANT RAT LYMPHOMA AND HUMAN OVARIAN-CARCINOMA CELLS, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 457-462
Citation: B. Mirakhur et al., EXPRESSION OF THE CISPLATIN RESISTANCE PHENOTYPE IN A HUMAN OVARIAN-CARCINOMA CELL-LINE SEGREGATES WITH CHROMOSOME-11 AND CHROMOSOME-16, Cancer research, 56(10), 1996, pp. 2256-2262
Citation: H. Parekh et H. Simpkins, SPECIES-SPECIFIC DIFFERENCES IN TAXOL TRANSPORT AND CYTOTOXICITY AGAINST HUMAN AND RODENT TUMOR-CELLS - EVIDENCE FOR AN ALTERNATE TRANSPORT-SYSTEM, Biochemical pharmacology, 51(3), 1996, pp. 301-311
Citation: Hk. Parekh et H. Simpkins, THE DIFFERENTIAL EXPRESSION OF CYTOKERATIN-18 IN CISPLATIN-SENSITIVE AND CISPLATIN-RESISTANT HUMAN OVARIAN ADENOCARCINOMA CELLS AND ITS ASSOCIATION WITH DRUG-SENSITIVITY, Cancer research, 55(22), 1995, pp. 5203-5206